United States Federal Circuit

Reset A A Font size: Print

Jazz Pharmaceuticals Inc. v. Amneal Pharmaceuticals LLC , 17-1671

Affirmed a finding of patent claim invalidity involving certain claims related to a drug distribution system for tracking prescriptions of sensitive drugs, such as those with addictive properties. In affirming, the Federal Circuit held that the Patent Trial and Appeal Board did not err and that its determination, on inter partes review, that the patents were invalid was obvious.

Appellate Information

  • Decided
  • Published 2018/07/13


  • Lourie


  • United States Federal Circuit